Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2PX topical therapy versus placebo for knee osteoarthritis pain
2008-008593-31Phase 3Completed
- Sponsor
- SantoSolve
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing 2PX topical treatment with Placebo vehicle control (2 arms). Primary endpoints: Change in WOMAC pain subscale score at 26 weeks and Change in WOMAC physical function subscale score at 26 weeks. Started Feb 2009; status: completed.
02
Drugs
strontium chloride hexahydrate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2008-008593-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008593-31.